Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSiemens Healthineers AG ADR

Siemens Healthineers AG ADR

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
24.12 USD -0.14 ( 0.58%)
Last update at 2026-11-03T20:59:00Z
VOLUME
4536
Market Cap
65206.76M
P/E
39.49

Momentum Score

…

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
24.09
Low
24.18
High
52 Week Price Range
23.80
Low
31.92
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Siemens Healthineers is a global medical technology company supplying diagnostic imaging, laboratory diagnostics, image-guided therapy systems and related services and software to hospitals and clinical labs. Long-term growth drivers include aging populations and rising diagnostic demand, expansion of digital and AI-enabled care solutions, growth in minimally invasive therapies and emerging-market penetration, which may benefit from its installed base, scale and R&D capabilities.

Key risks include pricing and reimbursement pressure, intense competition, capital-expenditure cyclicality at healthcare providers, regulatory and supply-chain challenges and foreign-exchange exposure that investors should monitor.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
24.26
Dividend Yield
1.73%
Revenue TTM
21680.00M
Revenue Per Share
9.68
Gross Profit TTM
8137.00M
Debt / Equity
-
ROE
8.03%
Net Debt
-
ROCE
6.42%
Diluted EPS TTM
0.74

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax 1928.00M 2800.00M 2404.00M 1954.00M 2193.00M
Minority interest -16.00M -17.00M -18.00M 13.00M 13.00M
Net income 1509.00M 2038.00M 1727.00M 1411.00M 1567.00M
Selling general administrative 3607.00M 3408.00M 2817.00M 2279.00M 2214.00M
Gross profit 7709.00M 8137.00M 6952.00M 5580.00M 5796.00M
Reconciled depreciation 1557.00M 1343.00M 1039.00M 815.00M 620.00M
Ebit - 2924.00M 2568.00M 1944.00M 2296.00M
Ebitda - 4261.00M 3526.00M 2845.00M 2936.00M
Operating income 2133.00M 2924.00M 2557.00M 1944.00M 2296.00M
Other operating expenses - 20.00M 21.00M 15.00M 42.00M
Interest expense 296.00M 118.00M 83.00M 76.00M 123.00M
Tax provision 403.00M 746.00M 658.00M 532.00M 607.00M
Interest income 85.00M 48.00M 33.00M 53.00M 38.00M
Net interest income -207.00M -127.00M -170.00M -28.00M -107.00M
Income tax expense - 746.00M 658.00M 532.00M 607.00M
Total revenue 21680.00M 21714.00M 17997.00M 14460.00M 14518.00M
Total operating expenses 19547.00M 18790.00M 15440.00M 12516.00M 12222.00M
Cost of revenue 13971.00M 13577.00M 11045.00M 8880.00M 8722.00M
Total other income expense net - - - - -104.00M
Net income from continuing ops 1525.00M 2054.00M 1746.00M 1422.00M 1586.00M
Net income applicable to common shares - 2038.00M 1727.00M 1411.00M 1567.00M
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 46684.00M 49056.00M 42162.00M 25094.00M 21429.00M
Intangible assets 7726.00M 8712.00M 8211.00M 1912.00M 1576.00M
Other current assets 25.00M 870.00M 269.00M 228.00M 119.00M
Total liab 28551.00M 29204.00M 25823.00M 12583.00M 11647.00M
Total stockholder equity 18081.00M 19836.00M 16321.00M 12498.00M 9769.00M
Other current liab 168.00M 5227.00M 4225.00M 2657.00M 2668.00M
Common stock - 1128.00M 1128.00M 1075.00M 1000.00M
Capital stock 1128.00M 1128.00M 1128.00M 1075.00M 1000.00M
Retained earnings 1381.00M 894.00M -300.00M -1276.00M -1859.00M
Other liab - 3369.00M 3594.00M 1998.00M 1951.00M
Good will 18118.00M 19061.00M 17512.00M 9038.00M 8590.00M
Other assets - 4070.00M 2141.00M 1254.00M 1429.00M
Cash 1642.00M 1436.00M 1322.00M 656.00M 920.00M
Total current liabilities 13440.00M 12024.00M 10113.00M 7289.00M 5604.00M
Short term debt - - - - 70.00M
Short long term debt 31.00M 67.00M 73.00M 60.00M 70.00M
Other stockholder equity - 18219.00M 15449.00M 12735.00M 10652.00M
Property plant equipment - 3632.00M 3295.00M 2510.00M 1944.00M
Total current assets 14136.00M 13379.00M 10782.00M 10268.00M 7779.00M
Long term investments - - - - 132.00M
Net tangible assets - -7937.00M -9493.00M 1548.00M -397.00M
Short term investments 124.00M 162.00M 79.00M 31.00M 28.00M
Net receivables 4420.00M 7064.00M 6012.00M 7080.00M 4676.00M
Long term debt 10.00M 15.00M 19.00M 49.00M 39.00M
Inventory 4261.00M 4009.00M 3179.00M 2304.00M 2064.00M
Accounts payable 2203.00M 2324.00M 1927.00M 1362.00M 1408.00M
Non currrent assets other 33.00M 27.00M 29.00M 14.00M 16.00M
Non current assets total 32548.00M 35677.00M 31338.00M 14827.00M 13650.00M
Capital lease obligations 592.00M 650.00M 590.00M 372.00M 32.00M
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments -1069.00M 15.00M 15.00M -1.00M -1.00M
Change to liabilities - 791.00M 643.00M 128.00M 268.00M
Total cashflows from investing activities - -868.00M -14140.00M -1912.00M -647.00M
Net borrowings - -169.00M -155.00M -101.00M 52.00M
Total cash from financing activities - -1644.00M 11839.00M -249.00M -603.00M
Change to operating activities - -663.00M 453.00M -39.00M -140.00M
Net income 1509.00M 2038.00M 1727.00M 1411.00M 1567.00M
Change in cash 206.00M 114.00M 666.00M -264.00M 401.00M
Begin period cash flow 1436.00M 1322.00M 656.00M 920.00M 519.00M
End period cash flow 1642.00M 1436.00M 1322.00M 656.00M 920.00M
Total cash from operating activities 2119.00M 2504.00M 2933.00M 1928.00M 1617.00M
Issuance of capital stock - 1.00M 2311.00M 2709.00M -
Depreciation 1557.00M 1220.00M 913.00M 716.00M 509.00M
Other cashflows from investing activities - - 1.00M 1.00M 1.00M
Dividends paid -1066.00M 955.00M 856.00M 798.00M 699.00M
Change to inventory -453.00M -481.00M -22.00M -332.00M -124.00M
Change to account receivables - -478.00M -720.00M 55.00M -485.00M
Sale purchase of stock -421.00M -309.00M -255.00M -67.00M -51.00M
Other cashflows from financing activities - -211.00M 10796.00M -1992.00M 95.00M
Change to netincome - -46.00M -187.00M -110.00M -89.00M
Capital expenditures 838.00M 852.00M 674.00M 557.00M 579.00M
Change in working capital -602.00M -831.00M 354.00M -188.00M -481.00M
Other non cash items 244.00M 303.00M 191.00M 140.00M 95.00M
Free cash flow 1281.00M 1652.00M 2259.00M 1371.00M 1038.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SMMNY
Siemens Healthineers AG ADR		 -0.14
0.58%		 24.12 39.49 21.10 3.01 3.25 2.95 16.92
ABT
Abbott Laboratories		 -
-%		 109.40 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -0.41
0.41%		 98.88 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 3.74
1.22%		 310.55 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 0.66
1.38%		 48.35 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Siemens Healthineers AG ADR

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Henkestrasse 127, Erlangen, Germany, 91052

49 9131 84 3385

https://www.siemens-healthineers.com

71000

Name Title Year Born
Dr. Bernhard Montag Pres, CEO & Chairman of Management Board 1969
Dr. Jochen Schmitz CFO & Member of Management Board 1966
Ms. Darleen Caron Chief HR Officer, Labor Director & Member of Management Board 1964
Ms. Elisabeth Staudinger Member of Management Board 1970
Mr. Marc Koebernick Head of Investor Relations NA
Dr. Michel Therin D.V.M., Ph.D. Pres of Advanced Therapies 1961
Christian Klaussner Exec. VP of Fin. NA
Andre Hartung Head of Imaging NA
Mr. Christopher A. Toth Head of Varian 1979
Carsten Bertram Head of Advanced Therapies NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…